457 related articles for article (PubMed ID: 31758423)
81. Peptidyl arginine deiminase inhibition suppresses arthritis via decreased protein citrullination in joints and serum with the downregulation of interleukin-6.
Kawaguchi H; Matsumoto I; Osada A; Kurata I; Ebe H; Tanaka Y; Inoue A; Umeda N; Kondo Y; Tsuboi H; Ishigami A; Sumida T
Mod Rheumatol; 2019 Nov; 29(6):964-969. PubMed ID: 30285515
[No Abstract] [Full Text] [Related]
82. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis.
Khandpur R; Carmona-Rivera C; Vivekanandan-Giri A; Gizinski A; Yalavarthi S; Knight JS; Friday S; Li S; Patel RM; Subramanian V; Thompson P; Chen P; Fox DA; Pennathur S; Kaplan MJ
Sci Transl Med; 2013 Mar; 5(178):178ra40. PubMed ID: 23536012
[TBL] [Abstract][Full Text] [Related]
83. [Peptidylarginine deiminase type4 (PADI4) role in immune system].
Seri Y; Shoda H; Matsumoto I; Sumida T; Fujio K; Yamamoto K
Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(3):154-9. PubMed ID: 24974927
[TBL] [Abstract][Full Text] [Related]
84. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
[TBL] [Abstract][Full Text] [Related]
85. The amount of citrullinated proteins in synovial tissue is related to serum anti-cyclic citrullinated peptide (anti-CCP) antibody levels.
Olivares-Martínez E; Hernández-Ramírez DF; Núñez-Álvarez CA; Cabral AR; Llorente L
Clin Rheumatol; 2016 Jan; 35(1):55-61. PubMed ID: 26255191
[TBL] [Abstract][Full Text] [Related]
86. Evaluating the docetaxel effect in an animal model of polyarthritis.
Alghulami OM; Jasim GA; Jasim SY
Inflammopharmacology; 2024 Jun; 32(3):1827-1838. PubMed ID: 38619760
[TBL] [Abstract][Full Text] [Related]
87. Anti-citrullinated protein antibodies as biomarkers in rheumatoid arthritis.
Trier NH; Houen G
Expert Rev Mol Diagn; 2023; 23(10):895-911. PubMed ID: 37578277
[TBL] [Abstract][Full Text] [Related]
88. Activation of Peptidylarginine Deiminase in the Salivary Glands of
Rodríguez-Rodríguez M; Herrera-Esparza R; Bollain Y Goytia JJ; Pérez-Pérez ME; Pacheco-Tovar D; Murillo-Vázquez J; Pacheco-Tovar G; Avalos-Díaz E
J Immunol Res; 2017; 2017():8959687. PubMed ID: 29318161
[TBL] [Abstract][Full Text] [Related]
89. Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activities.
Wood DD; Ackerley CA; Brand Bv; Zhang L; Raijmakers R; Mastronardi FG; Moscarello MA
Lab Invest; 2008 Apr; 88(4):354-64. PubMed ID: 18227806
[TBL] [Abstract][Full Text] [Related]
90. Citrullination Controls Dendritic Cell Transdifferentiation into Osteoclasts.
Krishnamurthy A; Ytterberg AJ; Sun M; Sakuraba K; Steen J; Joshua V; Tarasova NK; Malmström V; Wähämaa H; Réthi B; Catrina AI
J Immunol; 2019 Jun; 202(11):3143-3150. PubMed ID: 31019059
[TBL] [Abstract][Full Text] [Related]
91. Effects of iguratimod on glucocorticoid-induced disorder of bone metabolism in vitro.
Miyama A; Ebina K; Hirao M; Okamura G; Etani Y; Takami K; Goshima A; Miura T; Oyama S; Kanamoto T; Yoshikawa H; Nakata K
J Bone Miner Metab; 2021 Jul; 39(4):639-648. PubMed ID: 33564917
[TBL] [Abstract][Full Text] [Related]
92. Heightened autoantibody immune response to citrullinated calreticulin in bronchiectasis: Implications for rheumatoid arthritis.
Clarke A; Perry E; Kelly C; De Soyza A; Heesom K; Gold LI; Ollier W; Hutchinson D; Eggleton P
Int J Biochem Cell Biol; 2017 Aug; 89():199-206. PubMed ID: 28652209
[TBL] [Abstract][Full Text] [Related]
93. Genetic predictors of efficacy and toxicity of iguratimod in patients with rheumatoid arthritis.
Xiao W; Guo JP; Li C; Ye H; Wei W; Zou Y; Dai L; Li Z; Zhang M; Li X; Cai X; Zhao J; Wang Y; Tao Y; Liu D; Li Y; Wu M; Sun E; Wu L; Luo L; Mu R; Li Z
Pharmacogenomics; 2018 Apr; 19(5):383-392. PubMed ID: 29517409
[TBL] [Abstract][Full Text] [Related]
94. A novel disease-modifying antirheumatic drug, iguratimod, ameliorates murine arthritis by blocking IL-17 signaling, distinct from methotrexate and leflunomide.
Luo Q; Sun Y; Liu W; Qian C; Jin B; Tao F; Gu Y; Wu X; Shen Y; Xu Q
J Immunol; 2013 Nov; 191(10):4969-78. PubMed ID: 24123677
[TBL] [Abstract][Full Text] [Related]
95. Peptidylarginine deiminase 2 citrullinates MZB1 and promotes the secretion of IgM and IgA.
Geary B; Sun B; Tilvawala RR; Barasa L; Tsoyi K; Rosas IO; Thompson PR; Ho IC
Front Immunol; 2023; 14():1290585. PubMed ID: 38094295
[TBL] [Abstract][Full Text] [Related]
96. Tumor necrosis factor alpha, citrullination, and peptidylarginine deiminase 4 in lung and joint inflammation.
Bawadekar M; Gendron-Fitzpatrick A; Rebernick R; Shim D; Warner TF; Nicholas AP; Lundblad LK; Thompson PR; Shelef MA
Arthritis Res Ther; 2016 Jul; 18(1):173. PubMed ID: 27450561
[TBL] [Abstract][Full Text] [Related]
97. Peptidylarginine deiminase, the arginine to citrulline converting enzyme, is frequently recognized by sera of patients with rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren syndrome.
Nissinen R; Paimela L; Julkunen H; Tienari PJ; Leirisalo-Repo M; Palosuo T; Vaarala O
Scand J Rheumatol; 2003; 32(6):337-42. PubMed ID: 15080264
[TBL] [Abstract][Full Text] [Related]
98. Citrullination by peptidylarginine deiminase in rheumatoid arthritis.
Suzuki A; Yamada R; Yamamoto K
Ann N Y Acad Sci; 2007 Jun; 1108():323-39. PubMed ID: 17893996
[TBL] [Abstract][Full Text] [Related]
99. Citrullination of C1-inhibitor as a mechanism of impaired complement regulation in rheumatoid arthritis.
Martin M; Nilsson SC; Eikrem D; Fromell K; Scavenius C; Vogt LM; Bielecka E; Potempa J; Enghild JJ; Nilsson B; Ekdahl KN; Kapetanovic MC; Blom AM
Front Immunol; 2023; 14():1203506. PubMed ID: 37426666
[TBL] [Abstract][Full Text] [Related]
100. Peptidylarginine deiminases 2 and 4 modulate innate and adaptive immune responses in TLR-7-dependent lupus.
Liu Y; Lightfoot YL; Seto N; Carmona-Rivera C; Moore E; Goel R; O'Neil L; Mistry P; Hoffmann V; Mondal S; Premnath PN; Gribbons K; Dell'Orso S; Jiang K; Thompson PR; Sun HW; Coonrod SA; Kaplan MJ
JCI Insight; 2018 Dec; 3(23):. PubMed ID: 30518690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
